All-trans retinoic acid and gastric cancer cell resistance
Author Information
Author(s): TY Chao, SY Jiang, RY Shyu, MY Yeh, TM Chu
Primary Institution: National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan; Roswell Park Cancer Institute, Buffalo, NY, USA
Hypothesis
Does all-trans retinoic acid affect the sensitivity of gastric cancer cells to lymphokine-activated killer activity?
Conclusion
All-trans retinoic acid significantly increases the resistance of gastric cancer cells to lymphokine-activated killer cytotoxicity.
Supporting Evidence
- RA treatment led to a dose-dependent increase in resistance to LAK activity.
- The maximum resistance was observed after 6 days of treatment with RA.
- RA did not alter the binding efficacy between target SC-Mi cells and effector LAK cells.
Takeaway
This study found that a substance called all-trans retinoic acid helps stomach cancer cells become tougher against certain immune attacks.
Methodology
The study involved co-culturing gastric cancer cells with all-trans retinoic acid and assessing their resistance to lymphokine-activated killer cells through various assays.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo conditions.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website